<qa>  What is the purpose of this open-label postmarket study?The purpose of this open-label, postmarket study is to evaluate the safety and efficacy of transoral incisionless fundoplication TIF performed with EsophyX in a broad range of gastroesophageal reflux disease GERD patients treated at high volume centers across the United States. 